AAA Thierry Heles – Page 242

Cantargia files for IPO in Sweden

Cantargia, a Sweden-based biopharmaceutical company backed by life sciences business Lubio Science, has filed an initial public offering on the Nasdaq North First market in Stockholm, Sweden. The company plans to raise an initial SEK 44.1m ($5.4m) from the share issue, which would be increased to more than $12.2m if additional option rights are taken… Continue reading Cantargia files for IPO in Sweden

NeuroPhage boosts series D to $27m

NeuroPhage Pharmaceuticals, a US-based biotechnology company backed by pharmaceutical firms Shire and Mérieux, has closed a $27m series D round after securing $10m from undisclosed investors. The company initally raised $17m in March 2014 from Shire and Mérieux Développement, the healthcare investment unit of bioresearch corporation Institut Mérieux, in the first tranche of the round.… Continue reading NeuroPhage boosts series D to $27m

Apama ascends to series B

US-based medical device developer Apama Medical secured $11m of a planned $17.5m series B round on Tuesday from investors including Ascension Ventures, the corporate venturing arm of healthcare provider Ascension Health. Venture capital firms Onset Ventures and Incept also participated alongside several unnamed angel investors. Apama previously raised $3.2m from Broadview Ventures in a series… Continue reading Apama ascends to series B

Vidyard markets $18m series B

Canada-based video marketing platform Vidyard secured $18m yesterday in a series B round led by Bessemer Venture Partners that also included cloud computing company Salesforce.com’s corporate venturing arm, Salesforce Ventures. Omers Ventures, the investment arm of Ontario’s state pension fund, iNovia Capital and SoftTech VC all participated in the round as returning investors. Vidyard will… Continue reading Vidyard markets $18m series B

Investors transport $50m to Moovit series C

US-based transit app developer Moovit has secured $50m in a series C round that included Finland-based technology company Nokia’s corporate venturing unit Nokia Growth Partners and automotive company BMW’s corporate venturing arm BMW iVentures. Keolis, a transport group majority owned by railway company SNCF; Bernard Arnault Group, which is backed by luxury goods producer LVMH;… Continue reading Investors transport $50m to Moovit series C